Clinical significance of serum anti-granulocyte–macrophage colony-stimulating factor autoantibodies in patients with sarcoidosis and hypersensitivity pneumonitis

Clinical significance of serum anti-granulocyte–macrophage colony-stimulating factor autoantibodies in patients with sarcoidosis and hypersensitivity pneumonitis

Abstract Background Anti-granulocyte–macrophage colony-stimulating factor autoantibody (GMAb) has been recognized as a diagnostic biomarker for autoimmune pulmonary alveolar proteinosis (aPAP). The aims of this study were to know the incidence of increased level of serum GMAb in granulomatous lung d...

Full description

Bibliographic Details
Main Authors: Kanako Katayama, Masaki Hirose, Toru Arai, Kazuyoshi Hatsuda, Kazunobu Tachibana, Reiko Sugawara, Chikatoshi Sugimoto, Takahiko Kasai, Masanori Akira, Yoshikazu Inoue
Format: Article
Language:English
Published: BMC 2020-09-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Autoantibody
Granulocyte–macrophage colony-stimulating factor
Hypersensitivity pneumonitis
Pulmonary alveolar proteinosis
Sarcoidosis
Online Access:http://link.springer.com/article/10.1186/s13023-020-01546-x

Internet

http://link.springer.com/article/10.1186/s13023-020-01546-x

Similar Items